Skip to main content Accessibility help

Sinonasal cancer: an overview of the emerging subtypes

  • J S Virk (a1), J Chan (a2), L Dimitrov (a1), A Williamson (a1), A Sandison (a3), J Weir (a4) and P Clarke (a1)...



Advances in immunohistochemistry have spearheaded major developments in our understanding and classification of sinonasal tumours. In the last decade, several new distinct histopathological entities of sinonasal cancer have been characterised.


This review aims to provide a clinical update of the major emerging subtypes for the ENT surgeon and an overview of the management strategies available for this heterogeneous group of pathologies.


Although rare, knowledge of sinonasal neoplasm subtypes has implications for prognosis, treatment strategies and the development of novel therapeutic targets.


Corresponding author

Author for correspondence: Miss Lilia Dimitrov, ENT Department, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK E-mail:


Hide All

Miss L Dimitrov takes responsibility for the integrity of the content of the paper



Hide All
1Sanghvi, S, Khan, MN, Patel, NR, Yeldandi, S, Baredes, S, Eloy, JA. Epidemiology of sinonasal squamous cell carcinoma: a comprehensive analysis of 4994 patients. Laryngoscope 2014;124:7683
2Stelow, EB, Bishop, JA. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base. Head Neck Pathol 2017;11:315
3Lewis, JS Jr, Bishop, JA, Gillison, M, Westra, WH, Yarborough, WG. Tumours of the nasal cavity, paranasal sinuses and skull base: carcinomas: sinonasal undifferentiated carcinoma. In: El-Naggar, AK, Chan, JKC, Grandis, JR, Takata, T, Slootweg, PJ, eds. WHO Classification of Head and Neck Tumours. Lyon: IARC, 2017;1820
4Agaimy, A, Weichert, W. SMARCA4-deficient sinonasal carcinoma. Head Neck Pathol 2017;11:541–5
5Masliah-Planchon, J, Bieche, I, Guinebretiere, JM, Bourdeaut, F, Delattre, O. SWI/SNF chromatin remodeling and human malignancies. Annu Rev Pathol 2015;10:145–71
6Jelinic, P, Mueller, JJ, Olvera, N, Dao, F, Scott, SN, Shah, R et al. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat Genet 2014;46:424–6
7Herpel, E, Rieker, RJ, Dienemann, H, Muley, T, Meister, M, Harmann, A et al. SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens. Ann Diagn Pathol 2017;26:4751
8Jo, VY, Chau, NG, Hornick, JL, Krane, JF, Sholl, LM. Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma. Mod Pathol 2017;30:650–9
9Agaimy, A, Koch, M, Lell, M, Semrau, S, Dudek, W, Wachter, WL et al. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms. Am J Surg Pathol 2014;38:1274–81
10Bishop, JA, Antonescu, CR, Westra, WH. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract. Am J Surg Pathol 2014;38:1282–9
11French, CA, Kutok, JL, Faquin, WC, Toretsky, JA, Antonescu, CR, Griffin, CA et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 2004;22:4135–9
12French, CA, Miyoshi, I, Kubonishi, I, Grier, HE, Perez-Atayde, AR, Fletcher, JA. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 2003;63:304–7
13Haack, H, Johnson, LA, Fry, CJ, Crosby, K, Polakiewicz, RD, Stelow, EB et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 2009;33:984–91
14Lewis, JS Jr, Westra, WH, Thompson, LD, Barnes, L, Cardesa, A, Hunt, JL et al. The sinonasal tract: another potential “hot spot” for carcinomas with transcriptionally-active human papillomavirus. Head Neck Pathol 2014;8:241–9
15Bishop, JA, Guo, TW, Smith, DF, Wang, H, Ogawa, T, Pai, SI et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol 2013;37:185–92
16Larque, AB, Hakim, S, Ordi, J, Nadal, A, Diaz, A, del Pino, M. High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas. Mod Pathol 2014;27:343–51
17Bishop, JA, Andreasen, S, Hang, JF, Bullock, MJ, Chen, TY, Franchi, A et al. HPV-related multiphenotypic sinonasal carcinoma: an expanded series of 49 cases of the tumor formerly known as HPV-related carcinoma with adenoid cystic carcinoma-like features. Am J Surg Pathol 2017;41:1690–701
18Bishop, JA. Newly described tumor entities in sinonasal tract pathology. Head Neck Pathol 2016;10:2331
19Hwang, SJ, Ok, S, Lee, HM, Lee, E, Park, IH. Human papillomavirus-related carcinoma with adenoid cystic-like features of the inferior turbinate: a case report. Auris Nasus Larynx 2015;42:53–5
20Wang, X, Bledsoe, KL, Graham, RP, Asmann, YW, Viswanatha, DS, Lewis, JE et al. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet 2014;46:666–8
21Lewis, JT, Oliveira, AM, Nascimento, AG, Schembri-Wismayer, D, Moore, EA, Olsen, KD et al. Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol 2012;36:517–25
22Huang, SC, Ghossein, RA, Bishop, JA, Zhang, L, Chen, TC, Huang, HY et al. Novel PAX3-NCOA1 fusions in biphenotypic sinonasal sarcoma with focal rhabdomyoblastic differentiation. Am J Surg Pathol 2016;40:51–9
23Zur, KB, Brandwein, M, Wang, B, Som, P, Gordon, R, Urken, ML. Primary description of a new entity, renal cell-like carcinoma of the nasal cavity: van Meegeren in the house of Vermeer. Arch Otolaryngol Head Neck Surg 2002;128:441–7
24Storck, K, Hadi, UM, Simpson, R, Ramer, M, Brandwein-Gensler, M. Sinonasal renal cell-like adenocarcinoma: a report on four patients. Head Neck Pathol 2008;2:7580
25Fleming, KE, Perez-Ordonez, B, Nasser, JG, Psooy, B, Bullock, MJ. Sinonasal seromucinous hamartoma: a review of the literature and a case report with focal myoepithelial cells. Head Neck Pathol 2012;6:395–9
26Lee, DH, Yoon, TM, Lee, JK, Lim, SC. Seromucinous hamartoma of inferior turbinate: a case report. Medicine (Baltimore) 2018;97:e13022
27Virk, J, Dixon, L, Madani, G, Clarke, P. Anterior skull base and sinonasal surgery: dilemmas and complexities. In: Gibson, D, Manjaly, J, Tatla, T, eds. Head and Neck Imaging – A Multidisciplinary Team Approach. London: Springer, 2018
28Khoury, T, Jang, D, Carrau, R, Ready, N, Barak, I, Hachem, RA. Role of induction chemotherapy in sinonasal malignancies: a systematic review. Int Forum Allergy Rhinol 2019;9:212–19
29Patil, VM, Joshi, A, Noronha, V, Sharma, V, Zanwar, S, Dhumal, S et al. Neoadjuvant chemotherapy in locally advanced and borderline resectable nonsquamous sinonasal tumors (esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation). Int J Surg Oncol 2016;2016:6923730
30Noronha, V, Patil, VM, Joshi, A, Krishna, MV, Dhumal, S, Juvekar, S et al. Induction chemotherapy in technically unresectable locally advanced carcinoma of maxillary sinus. Chemother Res Prac 2014;2014:487872
31Ock, CY, Keam, B, Kim, TM, Han, DH, Won, TB, Lee, SH et al. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation. Korean J Intern Med 2016;31:570–8
32Lopez-Hernandez, A, Vivanco, B, Franchi, A, Bloemena, E, Cabal, VN, Potes, S et al. Genetic profiling of poorly differentiated sinonasal tumours. Sci Rep 2018;8:3998
33De Cecco, L, Serafini, MS, Facco, C, Granata, R, Orlandi, E, Fallai, C et al. A functional gene expression analysis in epithelial sinonasal cancer: biology and clinical relevance behind three histological subtypes. Oral Oncol 2019;90:94101
34van der Laan, TP, Iepsma, R, Witjes, MJ, van der Laan, BF, Plaat, BE, Halmos, GB. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: the importance of differentiation grade in determining treatment strategy. Oral Oncol 2016;63:19


Sinonasal cancer: an overview of the emerging subtypes

  • J S Virk (a1), J Chan (a2), L Dimitrov (a1), A Williamson (a1), A Sandison (a3), J Weir (a4) and P Clarke (a1)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.